MiR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 76, Issue 3, 2017, Pages 620-624

  Chen, L ^a   Al Mossawi, M H ^a   Ridley, A ^a   Sekine, T ^a   Hammitzsch, A ^a,b   De Wit, J ^a   Simone, D ^a   Shi, H ^a   Penkava, F ^a   Kurowska Stolarska, M ^c   Pulyakhina, I ^d   Knight, J C ^e   Kim, T J ^f   Bowness, P ^a,g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f Chonnam National University   (South Korea)

^g NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Ankylosing Spondylitis; Cytokines; T Cells

Indexed keywords

INTERLEUKIN 17; MICRORNA 10B; MICRORNA 10B 5P; MICRORNA 155; MICRORNA 155 5P; MICRORNA 210; MICRORNA 210 3P; UNCLASSIFIED DRUG; IL17A PROTEIN, HUMAN; INTERLEUKIN 6; MAP KINASE KINASE KINASE 7; MICRORNA; MIRN10 MICRORNA, HUMAN; MIRN155 MICRORNA, HUMAN; MIRN210 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; TRANSCRIPTOME; TUMOR NECROSIS FACTOR;

ANKYLOSING SPONDYLITIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUCIFERASE ASSAY; MAP3K7 GENE; PATHOGENICITY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REGULATOR GENE; RNA SEQUENCE; TH17 CELL; TRANSCRIPTOMICS; UPREGULATION; VALIDATION STUDY; ADULT; AGED; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENE SILENCING; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; MALE; MAP KINASE KINASE KINASES; MICRORNAS; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; TH17 CELLS; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 85010410396     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2016-210175     Document Type: Article

References (16)

1. Khan MA, van der Linden SM. A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum 1990;20:107-13.
2. Cortes A, Hadler J, Pointon JP, et al. International Genetics of Ankylosing Spondylitis Consortium (IGAS). Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 2013;45:730-8.
3. Jandus C, Bioley G, Rivals JP, et al. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008;58:2307-17.
4. Baeten D, Sieper J, Braun J, et al. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 2015;373:2534-48.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
6. O'Connell RM, Rao DS, Chaudhuri AA, et al. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010;10:111-22.
7. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol 2007;17:118-26.
8. Zhu S, Pan W, Song X, et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med 2012;18:1077-86.
9. Li Z, Wong SH, Shen J, et al. The Role of MicroRNAS in Ankylosing Spondylitis. Medicine (Baltimore) 2016;95:e3325.
10. O'Connell RM, Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010;33:607-19.
11. Niimoto T, Nakasa T, Ishikawa M, et al. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord 2010;11:209.
12. Wang H, Flach H, Onizawa M, et al. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol 2014;15:393-401.
13. Murugaiyan G, da Cunha AP, Ajay AK, et al. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest 2015;125:1069-80.
14. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449:682-8.
15. Li Z, Lei H, Luo M, et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer 2015;18:43-54.
16. Liang M. MicroRNA: a new entrance to the broad paradigm of systems molecular medicine. Physiol Genomics 2009;38:113-15.